Cargando…
Covid-19 Molecular Testing and Clinical Correlates
Autores principales: | Kanjilal, Sanjat, Tang, Yi-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Health Sciences Division
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755952/ http://dx.doi.org/10.1016/S0272-2712(22)00037-3 |
Ejemplares similares
-
A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic
por: Kanjilal, Sanjat, et al.
Publicado: (2022) -
147. Defining the Optimal Serial Testing Interval and Features for Identifying Patients with Early SARS-CoV-2 Infection
por: Kanjilal, Sanjat
Publicado: (2021) -
Prevalence, Clinical Characteristics, and Outcomes of Sepsis Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Versus Other Pathogens in Hospitalized Patients With COVID-19
por: Shappell, Claire N., et al.
Publicado: (2022) -
301. Penicillin Versus Cefazolin or Anti-staphylococcal Penicillins for Penicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aldhaeefi, Mohammed, et al.
Publicado: (2020) -
2274. Trends in Empiric Antibiotic Utilization for Patients Hospitalized with Community-Onset SARS-CoV-2 Infections and Viral Sepsis During the COVID-19 Pandemic
por: Shappell, Claire N, et al.
Publicado: (2023)